WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...

The president promised lower prices on medications for Americans, but the state's independent pharmacies doubt that will ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

Join Holmes Murphy’s Nick Karls and Den Bishop as they break down President Trump’s recent executive order on drug pricing ...

President Trump recently issued an executive order, aiming to lower prescription costs down for Americans by aligning prices ...

President Trumps May 12 executive order on drug pricing seeks to implement most-favored-nation (MFN) pricing, pressuring ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...